Chlamydia trachomatis today: Treatment, detection, immunogenetics and the need for a greater global understanding of chlamydial disease pathogenesis

Drugs of Today

Volumn 45, Issue SUPPL. B, 2009, Pages 25-31

  Dean, Deborah ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; LYMPHOTOXIN; OUTER MEMBRANE PROTEIN A; TETRACYCLINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VITAMIN D RECEPTOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; ECUADOR; FEMALE INFERTILITY; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOGENETICS; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; PROSTITUTION; REINFECTION; SCREENING; SEXUALLY TRANSMITTED DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AND CENTRAL AMERICA; TRACHOMA;

ANIMALS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DRUG RESISTANCE, BACTERIAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 71249100256     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (68)

1. Greub, G., Vanrompay, D., Stephens, R. et al. ICSP-Subcommittee on the Taxonomy of Chlamydiae. Chlamydia Basic Research Society: Little Rock, Arkansas, March 2009.
2. World Health Organization. Sexually Transmitted Diseases. Available from: http: //www.who.int/vaccine-research/diseases/soa-std/en/index1.html. Accessed Sept 21, 2009.
3. Anttila, T., Saikku, P., Koskela P. et al. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 2001, 285(1): 47-51. (Pubitemid 32042715)
4. Smith, J.S., Munoz, N., Herrero, R. et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 2002, 185(3): 324-331 (Pubitemid 34107245)
5. Koskela, P., Anttila, T., Bjorge, T. et al. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 2000, 85(1): 35-39
6. Galvin, S.R., Cohen, M.S. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol 2003, 2: 33-42.
7. Stamm, W.E., Jones, R.B., Batteiger, B.E. Part III. Infectious diseases and their etiologic agents, Section C. Chlamydial diseases. In: Mandell GL, Bennett JE, Dolin R, (eds.). Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. Churchill Livingston: Philadelphia 2005, 2239-2253
8. Karam, G.H., Martin, D.H., Flotte, T.R., Bonnarens, F.O., Joseph, J.R., Mroczkowski, T.F., Johnson, W.D. Asymptomatic Chlamydia trachomatis infections among sexually active men. J Infect Dis 1986, 154(5): 900-903
9. Pimenta, J.M., Catchpole, M., Rogers, P.A. et al. Opportunistic screening for genital chlamydial infection. II: Prevalence among healthcare attenders, outcome, and evaluation of positive cases. Sex Transm Infect 2003, 79(1): 22-27
10. Marrack, P., Kappler, J. Subversion of the immune system by pathogens. Cell 1994, 76(2): 323-332
11. Debattista, J., Timms, P., Allan, J. Immunopathogenesis of Chlamydia trachomatis infections in women. Fertil Steril 2003, 79(6): 1273-1287 (Pubitemid 36687872)
12. Brunham, R.C., Rey-Ladino, J. Immunology of Chlamydia infection: Implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 2005, 5(2): 149-161 (Pubitemid 40208904)
13. Dean, D., Suchland, R., Stamm, W.. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J Infect Dis 2000, 182(3): 909-916 (Pubitemid 30695389)
14. Hogan, R.J., Mathews, S.A., Mukhopadhyay, S., Summersgill, J.T., Timms, P. Chlamydial persistence: Beyond the biphasic paradigm. Infect Immun 2004, 72(4): 1843-1855 (Pubitemid 38419894)
15. Atik, B., Thanh, T.T., Luong, V.Q., Lagree, S., Dean, D. Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection. JAMA 2006, 296(12): 1488-1497 (Pubitemid 44465513)
16. West, S.K., Munoz, B., Mkocha, H. et al. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: A longitudinal study. Lancet 2005, 366(9493): 1296-1300 (Pubitemid 41416585)
17. Chidambaram, J.D., Alemayehu, W., Melese, M. et al. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. JAMA 2006, 295(10): 1142-1146 (Pubitemid 43352343)
18. West, S., Munoz, B., Bobo, L. et al. Nonocular Chlamydia infection and risk of ocular reinfection after mass treatment in a trachoma hyperendemic area. Invest Ophthalmol Vis Sci 1993, 34(11): 3194-3198 (Pubitemid 23309059)
19. Schachter, J., West, S.K., Mabey, D. et al. Azithromycin in control of trachoma. Lancet 1999, 354(9179): 630-635
20. West, S.K. Blinding trachoma: Prevention with the safe strategy. Am J Trop Med Hyg 2003, 69(5 Suppl.): 18-23.
21. Broman, A.T., Shum, K., Munoz, B., Duncan, D.D., West, S.K. Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania. Invest Ophthalmol Vis Sci 2006, 47(1): 99-104. (Pubitemid 46780801)
22. Somani, J., Bhullar, V.B., Workowski, K.A., Farshy, C.E., Black, C.M. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis 2000, 181: 1421-1427 (Pubitemid 30252548)
23. Misyurina, O.Y., Chipitsyna, E.V., Finashutina, Y.P., Lazarev, V.N., Akopian, T.A., Savicheva, A.M., Govorun, V.M. Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides. Antimicrob Agents Chemother 2004, 48(4): 1347-1349
24. Fry, A.M., Jha, H.C., Lietman, T.M. et al. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. Clin Infect Dis 2002, 35(4): 395-402.
25. Rahman, M., Shoma, S., Rashid, H. et al. Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: Resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin. J Health Popul Nutr 2007, 25(2): 158-167 (Pubitemid 47604194)
26. Dugan, J., Rockey, D.D., Jones, L., Andersen, A.A. Tetracycline resistance in Chlamydia suis mediated by genomic islands inserted into the chlamydial inv-like gene. Antimicrob Agents Chemother 2004, 48(10): 3989-3995 (Pubitemid 39304632)
27. Dean, D., Kandel, R.P., Adhikari, H.K., Hessel, T. Multiple Chlamydiaceae species in trachoma: Implications for disease pathogenesis and control. PLoS Med 2008, 5(1): e14. (Pubitemid 351198261)
28. Gomes, J.P., Bruno, W.J., Nunes, A., Santos, N., Florindo, C., Borrego, M.J., Dean, D. Evolution of Chlamydia trachomatis diversity occurs by widespread interstrain recombination involving hotspots. Genome Res 2007, 1: 50-60. (Pubitemid 46041665)
29. Rogers, S.M., Miller, W.C., Turner, C.F. et al. Concordance of Chlamydia trachomatis infections within sexual partnerships. Sex Transm Infect 2008, 84(1): 23-28 (Pubitemid 351195846)
30. Geister, W.M., Chow, J.M., Schachter, J., McCormack, W.M. Pelvic examination findings and Chlamydia trachomatis infection in asymptomatic young women screened with a nucleic acid amplification test. Sex Transm Dis 2007, 34(6): 335-338 (Pubitemid 46816778)
31. Jespersen, D.J., Flatten, K.S., Jones, M.F., Smith, T.F. Prospective comparison of cell cultures and nucleic acid amplification tests for laboratory diagnosis of Chlamydia trachomatis infections. J Clin Microbiol 2005, 43(10): 5324-5326
32. Gaydos, C.A. Nucleic acid amplification tests for gonorrhea and chlamydia: Practice and applications. Infect Dis Clin North Am 2005, 19(2): 367-86, ix.
33. Schachter, J., Moncada, J., Liska, S., Shayevich, C., Klausner, J.D. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis 2008, 35(7): 637-642
34. Schachter, J., Hook, E.W., Martin, D.H. et al. Confirming positive results of nucleic acid amplification tests (NAATs) for Chlamydia trachomatis: All NAATs are not created equal. J Clin Microbiol 2005, 43(3): 1372-1373 (Pubitemid 40364964)
35. An, Q., Olive, D.M. Molecular cloning and nucleic acid sequencing of Chlamydia trachomatis 16S rRNA genes from patient samples lacking the cryptic plasmid. Mol Cell Probes 1994, 8(5): 429-435 (Pubitemid 24360858)
36. Unemo, M., Olcen, P., Agne-Stadling, I. et al. Experiences with the new genetic variant of Chlamydia trachomatis in Orebro county, Sweden - proportion, characteristics and effective diagnostic solution in an emergent situation. Euro Surveill 2007, 12(4): E5-6.
37. McLean, C.A., Stoner, B.P., Workowski, K.A. Treatment of lymphogranuloma venereum. Clin Infect Dis 2007, 44(Suppl 3): S147-52.
38. Fine, D., Dicker, L., Mosure, D., Berman, S. Increasing chlamydia positivity in women screened in family planning clinics: Do we know why? Sex Transm Dis 2008, 35(1): 47-52.
39. Kapoor, S. Re-emergence of lymphogranuloma venereum. J Eur Acad Dermatol Venereol 2008, 22(4): 409-416
40. Stary, G., Meyer, T., Bangert, C. et al. New Chlamydia trachomatis L2 strains identified in a recent outbreak of lymphogranuloma venereum in Vienna, Austria. Sex Transm Dis 2008, 35(4): 377-382
41. Marshall, R., Chernesky, M., Jang, D. et al. Characteristics of the m2000 automated sample preparation and multiplex real-time PCR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol 2007, 45(3): 747-751 (Pubitemid 46427687)
42. Medina, M., Moya, W., Hidalgo, L., Calle, A., Teran, E., Chedraui, P. Molecular identification of endocervical Chlamydia trachomatis infection among gestations at risk for preterm birth in Ecuador. Arch Gynecol Obstet 2009, 279(1): 9-10.
43. Solomon, M.M., Smith, M.J., del Rio, C. Low educational level: A risk factor for sexually transmitted infections among commercial sex workers in Quito, Ecuador. Int J STD AIDS 2008, 19(4): 264-267
44. Soto, R.J., Ghee, A.E., Nunez, C.A. et al.; Estudio Multicentrico Study T. Sentinel surveillance of sexually transmitted infections/HIV and risk behaviors in vulnerable populations in 5 Central American countries. J Acquir Immune Defic Syndr 2007, 46(1): 101-111
45. Cuchacovich, R., Japa, S., Huang, W.Q. et al. Detection of bacterial DNA in Latin American patients with reactive arthritis by polymerase chain reaction and sequencing analysis. J Rheumatol 2002, 29(7): 1426-1429 (Pubitemid 34755609)
46. Gorter, A.C., Segura, Z.E., Savelkoul, P.H., Morre, S.A. Chlamydia trachomatis infections in Nicaragua: Preliminary results from a competitive voucher scheme to prevent and treat sexually transmitted infections and HIV/AIDS among sex workers. Drugs Today (Barc) 2006, 42(Suppl. A): 47-54.
47. Claeys, P., Gonzalez, C., Gonzalez, M., Van Renterghem, L., Temmerman, M. Prevalence and risk factors of sexually transmitted infections and cervical neoplasia in women's health clinics in Nicaragua. Sex Transm Infect 2002, 78(3): 204-207 (Pubitemid 34666541)
48. Paris, M., Gotuzzo, E., Goyzueta, G. et al. Prevalence of gonococcal and chlamydial infections in commercial sex workers in a Peruvian Amazon city. Sex Transm Dis 1999, 26(2): 103-107 (Pubitemid 29085310)
49. Ferrera, A., Baay, M.F., Herbrink, P., Figueroa, M., Velema, J.P., Melchers, W.J. A sero-epidemiological study of the relationship between sexually transmitted agents and cervical cancer in Honduras. Int J Cancer 1997, 73(6): 781-785 (Pubitemid 127483026)
50. Herrmann, B., Espinoza, F., Villegas, R.R., Smith, G.D., Ramos, A., Egger, M. Genital chlamydial infection among women in Nicaragua: Validity of direct fluorescent antibody testing, prevalence, risk factors and clinical manifestations. Genitourin Med 1996, 72(1): 20-26 (Pubitemid 26057870)
51. Gunn, R.A., Hillis, S.D., Shirey, P., Waterman, S.H., Greenspan, J.R. Chlamydia trachomatis infection among Hispanic women in the California-Mexico border area, 1993: establishing screening criteria in a primary care setting. Sex Transm Dis 1995, 22(6): 329-334
52. Venegas, V.S., Villafranca, P., Madrid, J.P., Cosenza, H., Bygdeman, S. Gonorrhoea and urogenital chlamydial infection in female prostitutes in Tegucigalpa, Honduras. Int J STD AIDS 1991, 2(3): 195-199
53. Goeman, J., Piot, P. The epidemiology of sexually transmitted diseases in Africa and Latin America. Semin Dermatol 1990, 9(2): 105-108 (Pubitemid 20218144)
54. Narvaez, M., Lopez Jaramillo, P., Guevara, A., Izurieta, A., Guderian, R. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae in 3 groups of Ecuadorian women with different sexual behaviors. Bol Oficina Sanit Panam 1989, 107(3): 220-225
55. Reeves, W.C., Quiroz, E. Prevalence of sexually transmitted diseases in high-risk women in the Republic of Panama. Sex Transm Dis 1987, 14(2): 69-74.
56. Baquerizo, L. Chlamydozoon oculogenitale, first discovery in Ecuador. Rev Ecuat Hig Med Trop 1955, 12(2): 11-14
57. Zhang, H., Kandel, R.P., Sharma, B., Dean, D. Risk factors for recurrence of postoperative trichiasis: Implications for trachoma blindness prevention. Arch Ophthalmol 2004, 122(4): 511-516 (Pubitemid 38456286)
58. Atik, B., Skwor, T.A., Kandel, R.P. et al. Identification of novel single nucleotide polymorphisms in inflammatory genes as risk factors associated with trachomatous trichiasis. PLoS ONE 2008, 3(10): e3600.
59. Conway, D.J., Holland, M.J., Bailey, R.L.et al. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid. Infect Immun 1997, 65(3): 1003-1006
60. Mozzato-Chamay, N., Mahdi, O.S., Jallow, O., Mabey, D.C., Bailey, R.L., Conway, D.J. Polymorphisms in candidate genes and risk of scarring trachoma in a Chlamydia trachomatis - endemic population. J Infect Dis 2000, 182(5): 1545-1548 (Pubitemid 30800966)
61. Natividad, A., Wilson, J., Koch, O. et al. Risk of trachomatous scarring and trichiasis in Gambians varies with SNP haplotypes at the interferon-gamma and interleukin-10 loci. Genes Immun 2005, 6(4): 332-340 (Pubitemid 40903406)
62. Natividad, A., Hanchard, N., Holland, M.J. et al. Genetic variation at the TNF locus and the risk of severe sequelae of ocular Chlamydia trachomatis infection in Gambians. Genes Immun 2007, 8: 288-295 (Pubitemid 46888036)
63. Natividad, A., Cooke, G., Holland, M.J. et al. A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection. BMC Med Genet 2006, 7: 40. (Pubitemid 44110343)
64. Cohen, C.R., Sinei, S.S., Bukusi, E.A., Bwayo, J.J., Holmes, K.K., Brunham, R.C. Human leukocyte antigen class II DQ alleles associated with Chlamydia trachomatis tubal infertility. Obstet Gynecol 2000, 95(1): 72-77
65. Kinnunen, A., Karhukorpi, J., Karttunen, R. et al. HLA DQ alleles among infertile Finnish women. In: Saikku, P. (ed.). 4th Meeting Europ Soc Chlamydia Res, Societa Editrice Esculapio (Helsinki, Aug 20-23) 2000, 193.
66. Gaur, L.K., Peeling, R.W., Cheang, M., Kimani, J., Bwayo, J., Plummer, F., Brunham, R.C.. Association of Chlamydia trachomatis heat-shock protein 60 antibody and HLA class II DQ alleles. J Infect Dis 1999, 180(1): 234-237 (Pubitemid 29293944)
67. Morre, S.A., Murillo, L.S., Bruggeman, C.A., Pena, A.S. The role that the functional Asp299Gly polymorphism in the Toll-like receptor-4 gene plays in susceptibility to Chlamydia trachomatis-associated tubal infertility. J Infect Dis 2003, 187(2): 341-342
68. den Hartog, J.E., Ouburg, S., Land, J.A., Lyons, J.M., Ito, J.I., Pena, A.S., Morre, S.A. Do host genetic traits in the bacterial sensing system play a role in the development of Chlamydia trachomatis-associated tubal pathology in subfertile women? BMC Infect Dis 2006, 6(122): 1-7.